Posted on June 9, 2009 by Debra A. McCurdy

Waxman Committee Hearing on FTC Follow-On Biologicals Report (June 11, 2009)

A House Energy and Commerce Health Subcommittee hearing on June 11, 2009 will focus on a new Federal Trade Commission (FTC) report titled "Emerging Health Care Issues: Follow-on Biologic Drug Competition."  The report will describe findings from an FTC nvestigation into the effects of a follow-on biologics pathway on competition and innovation. In particular, the report will address whether additional incentives, beyond those provided by patents and pricing, are needed to ensure continued innovation in the biologics market.

Tags: ,
Trackbacks (0) Links to blogs that reference this article Trackback URL
http://www.healthindustrywashingtonwatch.com/admin/trackback/138646
Comments (0) Read through and enter the discussion with the form at the end
Post A Comment / Question Use this form to add a comment to this entry.







Remember personal info?
Send To A Friend Use this form to send this entry to a friend via email.